Wesana Health Holdings Inc. (WSNAF)
USD 0.04
(135.29%)
USD 0.04
(135.29%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -1.12 Million USD | 60.83% |
| 2022 | -2.87 Million USD | 78.88% |
| 2021 | -13.59 Million USD | -15498.63% |
| 2020 | -87.18 Thousand USD | 14.86% |
| 2019 | -102.39 Thousand USD | -154.79% |
| 2018 | -40.18 Thousand USD | 0.0% |
| 2015 | -66.9 Thousand USD | 61.03% |
| 2014 | -171.69 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -103.93 Thousand USD | 37.5% |
| 2024 Q2 | -157.2 Thousand USD | -51.28% |
| 2023 FY | -1.12 Million USD | 60.83% |
| 2023 Q4 | -166.3 Thousand USD | 10.53% |
| 2023 Q1 | -445.82 Thousand USD | 27.59% |
| 2023 Q2 | -375.77 Thousand USD | 15.71% |
| 2023 Q3 | -185.87 Thousand USD | 50.53% |
| 2022 FY | -2.87 Million USD | 78.88% |
| 2022 Q4 | -615.68 Thousand USD | -189.03% |
| 2022 Q3 | 691.57 Thousand USD | 121.68% |
| 2022 Q2 | -3.19 Million USD | 30.72% |
| 2022 Q1 | -4.6 Million USD | 15.75% |
| 2021 Q3 | -4.05 Million USD | -52.86% |
| 2021 FY | -13.59 Million USD | -15498.63% |
| 2021 Q4 | -5.46 Million USD | -34.8% |
| 2021 Q1 | -1.42 Million USD | -2687.74% |
| 2021 Q2 | -2.65 Million USD | -86.01% |
| 2020 Q1 | -468.00 USD | 0.0% |
| 2020 Q4 | -51.15 Thousand USD | -81.68% |
| 2020 Q3 | -28.15 Thousand USD | -280.38% |
| 2020 Q2 | -7402.00 USD | -1481.62% |
| 2020 FY | -87.18 Thousand USD | 14.86% |
| 2019 FY | -102.39 Thousand USD | -154.79% |
| 2018 FY | -40.18 Thousand USD | 0.0% |
| 2015 FY | -66.9 Thousand USD | 61.03% |
| 2014 FY | -171.69 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1.33 Million USD | 15.765% |
| Arch Therapeutics, Inc. | -5.04 Million USD | 77.7% |
| Evofem Biosciences, Inc. | -17.84 Million USD | 93.697% |
| Nascent Biotech, Inc. | -2.22 Million USD | 49.553% |
| Rebus Holdings, Inc. | -664 Thousand USD | -69.414% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 101.374% |
| Qrons Inc. | -643.67 Thousand USD | -74.762% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -188.756% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | 97.973% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -170.749% |
| Skye Bioscience, Inc. | -13.67 Million USD | 91.772% |
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | 98.433% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 122.888% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -329.803% |
| SQZ Biotechnologies Company | -75.82 Million USD | 98.516% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | 60.537% |
| Propanc Biopharma, Inc. | -1.53 Million USD | 26.766% |
| Mesoblast Limited | -84.14 Million USD | 98.663% |
| Marizyme, Inc. | -34.08 Million USD | 96.7% |
| Genus plc | 6.4 Million USD | 117.577% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 111.546% |
| Pharming Group N.V. | -4.87 Million USD | 76.946% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | 43.372% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -20.778% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | 86.528% |
| ContraFect Corporation | -56.88 Million USD | 98.023% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | 75.302% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | 19.764% |
| IMV Inc. | -38.67 Million USD | 97.091% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | 59.107% |
| MultiCell Technologies, Inc. | -722.81 USD | -155529.557% |
| ONE Bio Corp. | 13.68 Million USD | 108.222% |
| Accustem Sciences Inc. | -3.74 Million USD | 69.974% |
| RVL Pharmaceuticals plc | -58.99 Million USD | 98.093% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -483.06 Thousand USD | -132.87% |
| Q BioMed Inc. | -3.44 Million USD | 67.353% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 131.777% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | 57.188% |
| Biomind Labs Inc. | -1 Million USD | -11.421% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | 97.954% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | 61.227% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | 83.079% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | 39.663% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -3655.696% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 92.912% |
| Curative Biotechnology, Inc. | -1.93 Million USD | 41.793% |
| GB Sciences, Inc. | -1.42 Million USD | 20.81% |
| Alpha Cognition Inc. | -9.7 Million USD | 88.41% |
| HST Global, Inc. | -140.9 Thousand USD | -698.332% |
| CSL Limited | 3.7 Billion USD | 100.03% |
| Halberd Corporation | -75.05 Thousand USD | -1398.875% |
| Enzolytics Inc. | -2.14 Million USD | 47.65% |
| Agentix Corp. | -1.37 Million USD | 17.995% |
| Resverlogix Corp. | -12.74 Million USD | 91.177% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | 64.495% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -425.04 Million USD | 99.735% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | -7.75% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | 61.468% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | 28.774% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | 66.963% |
| AVAX Technologies, Inc. | 6.69 Million USD | 116.808% |
| Zenith Capital Corp. | -8.94 Million USD | 87.421% |
| Genscript Biotech Corporation | -415.79 Million USD | 99.729% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -6357.184% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | 54.185% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -555.885% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | 43.888% |
| Kadimastem Ltd | -3.04 Million USD | 63.0% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | -14.314% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.25 Million USD | 10.437% |
| BioStem Technologies, Inc. | -7.77 Million USD | 85.539% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -519.834% |
| LadRx Corporation | -3.82 Million USD | 70.58% |
| Cell Source, Inc. | -4.32 Million USD | 73.993% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -63.754% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -63.754% |
| NovAccess Global Inc. | -2.46 Million USD | 54.397% |
| Affymax, Inc. | -15.04 Million USD | 92.524% |
| Itoco Inc. | -919.14 Thousand USD | -22.387% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | 73.459% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -0.528% |
| Mobile Lads Corp. | -554.55 Thousand USD | -102.85% |
| CytoDyn Inc. | -18.05 Million USD | 93.771% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -4369.233% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -411.14% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -99.196% |
| SYBLEU INC | -149.18 Thousand USD | -654.06% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | 38.067% |
| International Stem Cell Corporation | -663 Thousand USD | -69.669% |
| Bioxytran, Inc. | -3.82 Million USD | 70.553% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -2036.979% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -5430.511% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | 96.898% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | 30.476% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -52.875% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | 63.841% |
| Neutra Corp. | -229.48 Thousand USD | -390.185% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | 93.586% |
| PureTech Health plc | -146.19 Million USD | 99.231% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | 94.766% |
| IXICO plc | -1.43 Million USD | 21.718% |
| IntelGenx Technologies Corp. | -9.49 Million USD | 88.148% |
| Gelesis Holdings, Inc. | -121.8 Million USD | 99.076% |
| CSL Limited | 3.81 Billion USD | 100.03% |
| Cellectis S.A. | -108.85 Million USD | 98.967% |